Results 251 to 260 of about 198,913 (305)

Immunobiology of HPV and HPV vaccines

Gynecologic Oncology, 2008
Genital human papillomavirus (HPV) infection with both low- and high-risk types is common, but most infections resolve as a result of a cell-mediated immune response. Failure to induce an effective immune response is related to inefficient activation of innate immunity and ineffective priming of the adaptive immune response; this defective immune ...
openaire   +2 more sources

HPV vaccines

Best Practice & Research Clinical Obstetrics & Gynaecology, 2006
The ability to generate human papillomavirus virus (HPV)-like particles by the synthesis and self-assembly in vitro of the major virus capsid protein L1 has transformed our prospects for preventing cervical carcinoma in women. These particles provide vaccines that are immunogenic and safe, and data from proof-of-principle efficacy trials strongly ...
openaire   +2 more sources

Preclinical models of HPV+ and HPV− HNSCC in mice: An immune clearance of HPV+ HNSCC

Head & Neck, 2009
AbstractBackground.To investigate whether human papilloma virus (HPV)‐specific immune mechanisms can result in tumor clearance, we have created HPV+ and HPV− tonsil cells that form squamous cancers in immune‐competent mice. Here, we determine that an immune‐specific response can clear HPV+ tumor cells and the cellular requirements to mediate this tumor
Robin, Williams, Dong Wook, Lee, Bennett D, Elzey, Mary E, Anderson, Bruce S, Hostager, John H, Lee   +5 more
openaire   +2 more sources

Detection of HPV-20, HPV-23, and HPV-DL332 in a solitary eyelid syringoma

American Journal of Ophthalmology, 2000
To report evidence of many human papillomavirus types occurring in a solitary syringoma clinically appearing as a papilloma.A 57-year-old man presented with a 10-year history of an upper eyelid tumor. Histopathology, human papillomavirus-nested polymerase chain reaction, human papillomavirus-DNA cloning into vector pCR2.1, sequencing, and computer ...
A, Assadoullina, A A, Bialasiewicz, E M, de Villiers, G, Richard   +3 more
openaire   +2 more sources

HER2 and HER3 in HPV+ and HPV− HNSCC—Letter

Clinical Cancer Research, 2016
The nice experiments performed by Pollock and colleagues showed that Human papillomavirus (HPV) infection coincided with overexpression of HER2 (ERBB2), HER3 (ERBB3), and the associated HER2:HER3 heterodimer and that this may contribute to EGFR therapy resistance.
Jean-Pascal, Machiels, Rachel, Galot, Sandra, Schmitz   +2 more
openaire   +2 more sources

HPV and HPV‐associated cancer

Journal of Medical Virology, 2023
Xuefeng Liu, Nick Wallace
openaire   +2 more sources

HER2 and HER3 in HPV+ and HPV− HNSCC—Response

Clinical Cancer Research, 2016
We appreciate the perspective of Drs. Machiels, Galot and Schmitz of our article, which was published earlier this year in Clinical Cancer Research , prior to the publication of the LUX-Head and Neck 1 trial results.
openaire   +2 more sources

HPV

Educational Media Reviews Online, 2013
Distributed by Human Relations Media, 41 Kensico Drive, Mt. Kisco, NY 10549; 800-431-2050Produced by Human Relations Media, Inc.Directed by Peter Cochran2013, DVD, color, 18 min. The producers at Human Relations Media have created an informative resource that librarians will want to add to their collections and recommend for instructional use.
Claudia E. Rübe, Bernadine R. Donahue, Jay S. Cooper, Caspian Oliai, Yan Yu, Laura Doyle, Rene Rubin, Darek Michalski, M. Saiful Huq, Filip T. Troicki, Jaganmohan Poli, Carlos A. Perez, Wade L. Thorstad, Filip T. Troicki, Jaganmohan Poli, Lindsay G. Jensen, Brent S. Rose, Arno J. Mundt, Lindsay G. Jensen, Brent S. Rose, Arno J. Mundt, Lindsay G. Jensen, Brent S. Rose, Arno J. Mundt, Lindsay G. Jensen, Brent S. Rose, Arno J. Mundt, Caspian Oliai, Lindsay G. Jensen, Brent S. Rose, Arno J. Mundt, Filip T. Troicki, Jaganmohan Poli, Anthony E. Dragun, Rene Rubin, Stephan Mose, Christin A. Knowlton, Michelle Kolton Mackay, Bradley J. Huth, Claus Roedel, Stephan Mose, Stephan Mose, Erik Limbergen, Brandon J. Fisher, Larry C. Daugherty, Rene Rubin, Tod W. Speer, Hans-Peter Heilmann, Theodore E. Yaeger, Rene Rubin, Feng-Ming Kong, Jingbo Wang, Christin A. Knowlton, Michelle Kolton Mackay, Patrizia Guerrieri, Paolo Montemaggi, Gerhard G. Grabenbauer, Stephan Mose, Tod W. Speer, Patrizia Guerrieri, Paolo Montemaggi, Volker Budach, Carsten Nieder, Talha Shaikh, Jacqueline Emrich, Lydia T. Komarnicky-Kocher, Darek Michalski, M. Saiful Huq, Ramesh Rengan, Charles R. Thomas, Christin A. Knowlton, Michelle Kolton Mackay   +71 more
openaire   +2 more sources

Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine.

Reviews in obstetrics & gynecology, 2011
Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and persistent HPV infection is strongly associated with risk of cervical cancer and genital warts. The recently approved quadrivalent HPV vaccine targets the HPV strains responsible for approximately 70% of cervical cancers and 90% of genital warts.
Kari P, Braaten, Marc R, Laufer
openaire   +1 more source

HPV Type Replacement After HPV Vaccination

Human papillomavirus (HPV) vaccination effectively reduces the risk of HPV-attributable cancers, including cervical, vulvar, vaginal, anal, oropharyngeal, and other head and neck cancers. Concerns for a lower-than-expected vaccine impact, as defined as an increase in the prevalence of precancer by nonvaccine types, compared to that anticipated based on
Elizabeth M, Anderson, Alfred J, Saah, Joseph E, Tota   +2 more
openaire   +2 more sources